100
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Pattern Recognition Molecules of Lectin Complement Pathway in Ischemic Stroke

ORCID Icon, , , , &
Pages 1347-1368 | Published online: 21 Oct 2021

References

  • Mackay J, Mensah GA The atlas of heart disease and stroke. World health organization and center for disease control and prevention; 2015. Available from: http://www.who.int/cardiovascular_diseases/resources/atlas/en/. Accessed October 2, 2021.
  • Koton S, Schneider AL, Rosamond WD, et al. Stroke incidence and mortality trends in US communities, 1987 to 2011. JAMA. 2014;312(3):259–268. doi:10.1001/jama.2014.7692
  • Feigin VL, Krishnamurthi R. Stroke prevention in the developing world. Stroke. 2011;42(12):3655–3658. doi:10.1161/STROKEAHA.110.596858
  • Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007;6:182–187. doi:10.1016/S1474-4422(07)70031-5
  • Andreasyan D, Bazarchyan A, Matevosyan M, et al. “Health and Health Care” Yearbook Republic of Armenia 2020. Yerevan: National Institute of Health after named after academician S. Avdalbekyan MoH; 2020.
  • Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol. 2006;147(Suppl 1):S232–S240. doi:10.1038/sj.bjp.0706400
  • Mollnes TE, Song WC, Lambris JD. Complement in inflammatory tissue damage and disease. Trends Immunol. 2002;23(2):61–64. doi:10.1016/S1471-4906(01)02129-9
  • Fujita T. Evolution of the lectin-complement pathway and its role in innate immunity. Nat Rev Immunol. 2002;2(5):346–353. doi:10.1038/nri800
  • Liu Y, Endo Y, Iwaki D, et al. Human M-ficolin is a secretory protein that activates the lectin complement pathway. J Immunol. 2005;175(5):3150–3156. doi:10.4049/jimmunol.175.5.3150
  • Hansen S, Selman L, Palaniyar N, et al. Collectin 11 (CL-11, CL-K1) is a MASP-1/3-associated plasma collectin with microbial-binding activity. J Immunol. 2010;185(10):6096–6104. doi:10.4049/jimmunol.1002185
  • Boyajyan AS, Tsakanova GV, Zhamgaryan LG, et al. Involvement of the complement lectin pathway in postischemic inflammatory response. Cytokines Inflammation. 2010;9(3):35–39.
  • Thiel S, Gadjeva M. Humoral pattern recognition molecules: mannan-binding lectin and ficolins. Adv Exp Med Biol. 2009;653:58–73.
  • Holmskov U, Thiel S, Jensenius JC. Collectins and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol. 2003;21:547–578. doi:10.1146/annurev.immunol.21.120601.140954
  • Tsakanova G, Stepanyan A, Nahapetyan K, et al. Serine proteases of the complement lectin pathway and their genetic variations in ischaemic stroke. J Clin Pathol. 2018;71(2):141–147. doi:10.1136/jclinpath-2017-204403
  • Degn SE, Jensenius JC, Bjerre M. The lectin pathway and its implications in coagulation, infections and auto-immunity. Curr Opin Organ Transplant. 2011;16(1):21–27. doi:10.1097/MOT.0b013e32834253df
  • Petersen SV, Thiel S, Jensenius JC. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol. 2001;38(2–3):133–149. doi:10.1016/S0161-5890(01)00038-4
  • Møller-Kristensen M, Wang W, Ruseva M, et al. Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury. Scand J Immunol. 2005;61(5):426–434. doi:10.1111/j.1365-3083.2005.01591.x
  • Cervera A, Planas AM, Justicia C, et al. Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke. PLoS One. 2010;5(2):e8433. doi:10.1371/journal.pone.0008433
  • Larsen F, Madsen HO, Sim RB, et al. Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein. J Biol Chem. 2004;279(20):21302–21311. doi:10.1074/jbc.M400520200
  • Garred P, Thiel S, Madsen HO, et al. Gene frequency and partial protein characterization of an allelic variant of mannan binding protein associated with low serum concentrations. Clin Exp Immunol. 1992;90(3):517–521. doi:10.1111/j.1365-2249.1992.tb05876.x
  • Beltrame MH, Catarino SJ, Goeldner I, et al. The lectin pathway of complement and rheumatic heart disease. Front Pediatr. 2015;2:148. doi:10.3389/fped.2014.00148
  • Sastry K, Herman GA, Day L, et al. The human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10. J Exp Med. 1989;170(4):1175–1189. doi:10.1084/jem.170.4.1175
  • Taylor ME, Brickell PM, Craig RK, et al. Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein. Biochem J. 1989;262(3):763–771. doi:10.1042/bj2620763
  • Sjöberg AP, Manderson GA, Mörgelin M, et al. Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation. Mol Immunol. 2009;46(5):830–839. doi:10.1016/j.molimm.2008.09.018
  • Swingler TE, Waters JG, Davidson RK, et al. Degradome expression profiling in human articular cartilage. Arthritis Res Ther. 2009;11(3):R96. doi:10.1186/ar2741
  • Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol. 2003;40:423–429. doi:10.1016/S0161-5890(03)00155-X
  • Turner MW, Hamvas RM. Mannose-binding lectin: structure, function, genetics and disease associations. Rev Immunogenet. 2000;2(3):305–322.
  • Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today. 1996;17(11):532–540. doi:10.1016/S0167-5699(96)80908-X
  • Madsen HO, Garred P, Thiel S, et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol. 1995;155(6):3013–3020.
  • Madsen HO, Satz ML, Hogh B, et al. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol. 1998;161(6):3169–31675.
  • Wallis R. Structural and functional aspects of complement activation by mannose-binding protein. Immunobiology. 2002;205(4–5):433–445. doi:10.1078/0171-2985-00144
  • Wallis R, Drickamer K. Molecular determinants of oligomer formation and complement fixation in mannose-binding proteins. J Biol Chem. 1999;274(6):3580–3589. doi:10.1074/jbc.274.6.3580
  • Matsushita M, Ezekowitz RA, Fujita T. The Gly-54-Asp allelic form of human mannose-binding protein (MBP) fails to bind MBP-associated serine protease. Biochem J. 1995;311(Pt 3):1021–1023. doi:10.1042/bj3111021
  • Steffensen R, Thiel S, Varming K, et al. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods. 2000;241(1–2):33–42. doi:10.1016/S0022-1759(00)00198-8
  • Lipscombe RJ, Sumiya M, Summerfield JA, et al. Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype. Immunology. 1995;85(4):660–667.
  • Ammitzbøll CG, Kjær TR, Steffensen R, et al. Non-synonymous polymorphisms in the FCN1 gene determine ligand-binding ability and serum levels of M-ficolin. PLoS One. 2012;7(11):e50585. doi:10.1371/journal.pone.0050585
  • Munthe-Fog L, Hummelshoj T, Honoré C, et al. Variation in FCN1 affects biosynthesis of ficolin-1 and is associated with outcome of systemic inflammation. Genes Immun. 2012;13(7):515–522. doi:10.1038/gene.2012.27
  • Garred P, Honore C, Ma YJ, et al. The genetics of ficolins. J Innate Immun. 2010;2(1):3–16. doi:10.1159/000242419
  • Hummelshoj T, Munthe-Fog L, Madsen HO, et al. Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2. Hum Mol Genet. 2005;14(12):1651–1658. doi:10.1093/hmg/ddi173
  • Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24(1):35–41. doi:10.1161/01.STR.24.1.35
  • Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual. 3rd ed. USA: Cold Spring Harbor Laboratory Press; 2001.
  • Thiel S, Møller-Kristensen M, Jensen L, et al. Assays for the functional activity of the mannan-binding lectin pathway of complement activation. Immunobiology. 2002;205(4–5):446–454. doi:10.1078/0171-2985-00145
  • Wittenborn T, Thiel S, Jensen L, et al. Characteristics and biological variations of M-ficolin, a pattern recognition molecule, in plasma. J Innate Immun. 2010;2(2):167–180. doi:10.1159/000218324
  • Henckaerts L, Nielsen KR, Steffensen R, et al. Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Crit Care Med. 2009;37(1):192–201.e1–3. doi:10.1097/CCM.0b013e31819263d8
  • Mølle I, Steffensen R, Thiel S, et al. Chemotherapy-related infections in patients with multiple myeloma: associations with mannan-binding lectin genotypes. Eur J Haematol. 2006;77(1):19–26. doi:10.1111/j.1600-0609.2006.00669.x
  • Mandal J, Malla B, Steffensen R, et al. Mannose-binding lectin protein and its association to clinical outcomes in COPD: a longitudinal study. Respir Res. 2015;16:150. doi:10.1186/s12931-015-0306-3
  • Boldt AB, Sanchez MI, Stahlke ER, et al. Susceptibility to leprosy is associated with M-ficolin polymorphisms. J Clin Immunol. 2013;33(1):210–219. doi:10.1007/s10875-012-9770-4
  • Yoo J, Lee Y, Kim Y, et al. SNPAnalyzer 2.0: a web-based integrated workbench for linkage disequilibrium analysis and association analysis. BMC Bioinform. 2008;9:290. doi:10.1186/1471-2105-9-290
  • Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science. 2002;296(5576):2225–2229. doi:10.1126/science.1069424
  • Zangari R, Zanier ER, Torgano G, et al. Early ficolin-1 is a sensitive prognostic marker for functional outcome in ischemic stroke. J Neuroinflammation. 2016;13(1):16. doi:10.1186/s12974-016-0481-2
  • Wang ZY, Sun ZR, Zhang LM. The relationship between serum mannose-binding lectin levels and acute ischemic stroke risk. Neurochem Res. 2004;39(2):248–253. doi:10.1007/s11064-013-1214-x
  • Wallis R, Cheng JY. Molecular defects in variant forms of mannose-binding protein associated with immunodeficiency. J Immunol. 1999;163(9):4953–4959.
  • Brouwer N, Dolman KM, van Zwieten R, et al. Mannan-binding lectin (MBL)-mediated opsonization is enhanced by the alternative pathway amplification loop. Mol Immunol. 2006;43(13):2051–2060. doi:10.1016/j.molimm.2006.01.003
  • Nauta AJ, Castellano G, Xu W, et al. Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells. J Immunol. 2004;173(5):3044–3050. doi:10.4049/jimmunol.173.5.3044
  • Dommett RM, Klein N, Turner MW. Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens. 2006;68(3):193–209. doi:10.1111/j.1399-0039.2006.00649.x
  • de Messias-reason IJ, Boldt AB, Moraes Braga AC, et al. The association between mannan-binding lectin gene polymorphism and clinical leprosy: new insight into an old paradigm. J Infect Dis. 2007;196(9):1379–1385. doi:10.1086/521627
  • Fumagalli S, De Simoni MG. Lectin complement pathway and its bloody interactions in brain ischemia. Stroke. 2016;47(12):3067–3073. doi:10.1161/STROKEAHA.116.012407
  • Endo Y, Matsushita M, Fujita T. The role of ficolins in the lectin pathway of innate immunity. Int J Biochem Cell Biol. 2011;43(5):705–712. doi:10.1016/j.biocel.2011.02.003
  • Endo Y, Nakazawa N, Iwaki D, Takahashi M, Matsushita M, Fujita T. Interactions of ficolin and mannose-binding lectin with fibrinogen/fibrin augment the lectin complement pathway. J Innate Immun. 2010;2(1):33–42. doi:10.1159/000227805
  • Zhang N, Zhuang M, Ma A, et al. Association of levels of mannose-binding lectin and the MBL2 gene with type 2 diabetes and diabetic nephropathy. PLoS One. 2013;8(12):e83059. doi:10.1371/journal.pone.0083059
  • Krarup A, Thiel S, Hansen A, et al. L-ficolin is a pattern recognition molecule specific for acetyl groups. J Biol Chem. 2004;279(46):47513–47519. doi:10.1074/jbc.M407161200
  • Mason CP, Tarr AW. Human lectins and their roles in viral infections. Molecules. 2015;20(2):2229–2271. doi:10.3390/molecules20022229
  • Theoret JK, Jadavji NM, Zhang M, et al. Granulocyte macrophage colony-stimulating factor treatment results in recovery of motor function after white matter damage in mice. Eur J Neurosci. 2016;43(1):17–24. doi:10.1111/ejn.13105
  • Navarro-Sobrino M, Rosell A, Penalba A, et al. Role of endogenous granulocyte-macrophage colony stimulating factor following stroke and relationship to neurological outcome. Curr Neurovasc Res. 2009;6(4):246–251. doi:10.2174/156720209789630366
  • Vander Cruyssen B, Nuytinck L, Boullart L, et al. Polymorphisms in the ficolin 1 gene (FCN1) are associated with susceptibility to the development of rheumatoid arthritis. Rheumatology. 2007;46(12):1792–1795. doi:10.1093/rheumatology/kem266
  • Addobbati C, de Azevêdo Silva J, Tavares NA, et al. Ficolin gene polymorphisms in systemic lupus erythematosus and rheumatoid arthritis. Ann Hum Genet. 2016;80(1):1–6. doi:10.1111/ahg.12129
  • Anjosa ZP, Santos MM, Rodrigues NJ, et al. Polymorphism in ficolin-1 (FCN1) gene is associated with an earlier onset of type 1 diabetes mellitus in children and adolescents from northeast Brazil. J Genet. 2016;95(4):1031–1034. doi:10.1007/s12041-016-0719-x
  • Chen X, Katoh Y, Nakamura K, et al. Single nucleotide polymorphisms of Ficolin 2 gene in Behcet’s disease. J Dermatol Sci. 2006;43(3):201–205. doi:10.1016/j.jdermsci.2006.05.010
  • de Messias-reason I, Kremsner PG, Kun JF. Functional haplotypes that produce normal ficolin-2 levels protect against clinical leprosy. J Infect Dis. 2009;199(6):801–804. doi:10.1086/597070
  • Faik I, Oyedeji SI, Idris Z, et al. Ficolin-2 levels and genetic polymorphisms of FCN2 in malaria. Hum Immunol. 2011;72(1):74–79. doi:10.1016/j.humimm.2010.10.003
  • Messias-Reason IJ, Schafranski MD, Kremsner PG, et al. Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease. Clin Exp Immunol. 2009;157(3):395–399. doi:10.1111/j.1365-2249.2009.03975.x
  • Ruskamp JM, Hoekstra MO, Postma DS, et al. Exploring the role of polymorphisms in ficolin genes in respiratory tract infections in children. Clin Exp Immunol. 2009;155(3):433–440. doi:10.1111/j.1365-2249.2008.03844.x
  • Hoang TV, Toan NL, Song LH, et al. Ficolin-2 levels and FCN2 haplotypes influence hepatitis B infection outcome in Vietnamese patients. PLoS One. 2011;6(11):e28113. doi:10.1371/journal.pone.0028113
  • Ojurongbe O, Ouf EA, Van Tong H, et al. Reliable and rapid characterization of functional FCN2 gene variants reveals diverse geographical patterns. BMC Med Genet. 2012;13:37. doi:10.1186/1471-2350-13-37
  • Assaf A, Hoang TV, Faik I, et al. Genetic evidence of functional ficolin-2 haplotype as susceptibility factor in cutaneous leishmaniasis. PLoS One. 2012;7(3):e34113. doi:10.1371/journal.pone.0034113
  • Xu DD, Wang C, Jiang F, et al. Association of the FCN2 gene single nucleotide polymorphisms with susceptibility to pulmonary tuberculosis. PLoS One. 2015;10(9):e0138356. doi:10.1371/journal.pone.0138356
  • Olszowski T, Milona M, Janiszewska-Olszowska J, et al. The lack of association between FCN2 gene promoter region polymorphisms and dental caries in Polish children. Caries Res. 2017;51(1):79–84. doi:10.1159/000455054
  • Fumagalli S, Ortolano F, De Simoni MG. A close look at brain dynamics: cells and vessels seen by in vivo two-photon microscopy. Prog Neurobiol. 2014;121:36–54. doi:10.1016/j.pneurobio.2014.06.005
  • Del Zoppo GJ, Mabuchi T. Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab. 2003;23(8):879–894. doi:10.1097/01.WCB.0000078322.96027.78
  • United Nations Report. Human development report 2016. Human development for everyone. United Nations Development Programme; 2017. New York: One Unite Nations Plaza. Available from: http://hdr.undp.org/sites/default/files/2016_human_development_report.pdf. Accessed October 2, 2021.
  • Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073–1081. doi:10.1038/nprot.2009.86